Glenmark Pharma: The drug firm reported a 6.62 percent rise in its consolidated net profit to Rs 161.66 crore for the fourth quarter ended March 31. Consolidated revenue stood at Rs 2,563.47 crore for the quarter, compared to Rs 2,279.81 crore a year ago. (Image: Company)
{}